NOX

5.75%

8.2¢ noxopharm limited

Excellent roundup of progress to date RBx. A timely reminder of...

First 2 Last

Share
Profile

Follow
applefoot

392 Posts.

132

23/08/21

11:49

Post #: 55494686
Share
Originally posted by RBx ↑

In NOXCOVID, 37 of 38 patients achieved the equivalent of a Complete Response.

Veyonda continues to rack up impressive data. We know about LuPIN results, in which median survival of 19.7 months was achieved in patients with metastatic CRPC; we know about DARRT-1 results, which generated a number of abscopal responses in end-stage prostate patients; we know that its combination with chemo enabled the carboplatin dose to be reduced to non-toxic levels without affecting efficacy; and now we know that 37 of 38 COVID patients with moderate disease were virtually free of the disease after 14 days.

It is true that larger clinical trials are required, but the evidence so far suggests that Veyonda improves the performance of cancer treatments, and that the same drug has anti-inflammatory properties that benefit patients hospitalized with moderate COVID-19.

By dissolving Idronoxil in a propriety suppository base, Noxopharm has achieved a half-life of over 10 hours for Veyonda, which means that it only needs to be administer twice per day to have 24 hour coverage at therapeutic dose levels.

Using a suppository might not appeal to everyone, but consider this:

If it works, who cares?

Veyonda is SAFE to use

It can be self-administered at home

The unvaccinated will face the threat of death or serious infection for years to come

The action of Veyonda against key cytokines appears able to prevent long-COVID, which threatens to be the worst effect of the COVID-19 virus.

The likely affordability of Veyonda means that it could be widely used as a preventative.

Happy days!

Expand

Excellent roundup of progress to date RBx.

A timely reminder of the stand-out points that are arriving thick and fast…. not only on cancer but now on Covid too. SO FAST it transpires that since you penned this post earlier today….. we now have another extremely interesting piece of news regarding Veyonda and the new TBK1 target.

Oh well!!…. Newsflow has to be continuously updated I guess ….. to be so aptly named. Here’s hoping you will forever be just one step behind…. ‘Cos that will mean it just keeps on coming mate. (grin)

Apples
NOX Price at posting: 58.0¢ Sentiment: Buy Disclosure: Held
8 Upvote

0 Great analysis

Reply

Top Stories

VTM

Victory Metals dips -8% even as company set to grow heavy REE resource at North Stanmore

ARD

Argent begins search for VMS mineralisation at Kempfield Cu-Pb-Zn-Au-Ag play in NSW

M2R

EIS co-funded campaign sees Miramar kick off maiden drilling at Bangemall, Gascoyne WA

SVL

Court of Appeal upholds environmental group's challenge to Silver Mines Ltd's Bowden project

IMD

IMDEX to receive $10M in out-of-court settlement with Boart Longyear over downhole tool patent

EQR

EQ Resources transitions historic Mt Carbine tungsten mine to owner-operator system

Bitcoin: Current State of Play & Where to Next | Swyftx

WNX

Wellnex sees first special access scheme prescriptions for new Wellness Life brand

Week 33 Wrap: US recession fears forgotten; RBNZ’s surprise rate cut; more iron ore trouble

Emerald & Azure score Digger & Dealer awards

There are more pages in this discussion • 28 more messages in this thread...

First 2 Last

Add NOX (ASX) to my watchlist

(20min delay)
Last 8.2¢		Change -0.005(5.75%)		Mkt cap ! $23.96M

Open	High	Low	Value	Volume
8.7¢	8.7¢	8.1¢	$50.65K	608.4K

Buyers (Bids)

No.	Vol.	Price($)
3	131400	8.2¢

Sellers (Offers)

Price($)	Vol.	No.
8.6¢	7168	1

View Market Depth

No.	Vol.	Price($)
3	131400	0.082
2	170000	0.081
2	200000	0.080
1	15000	0.078
1	14091	0.077

Price($)	Vol.	No.
0.086	7168	1
0.091	10989	1
0.093	37410	1
0.095	54200	2
0.096	35000	1

Last trade - 16.10pm 16/08/2024 (20 minute delay)

NOX (ASX) Chart

Excellent roundup of progress to date RBx. A timely reminder of...

Victory Metals dips -8% even as company set to grow heavy REE resource at North Stanmore

Argent begins search for VMS mineralisation at Kempfield Cu-Pb-Zn-Au-Ag play in NSW

EIS co-funded campaign sees Miramar kick off maiden drilling at Bangemall, Gascoyne WA

Court of Appeal upholds environmental group's challenge to Silver Mines Ltd's Bowden project

IMDEX to receive $10M in out-of-court settlement with Boart Longyear over downhole tool patent

EQ Resources transitions historic Mt Carbine tungsten mine to owner-operator system

Bitcoin: Current State of Play & Where to Next | Swyftx

Wellnex sees first special access scheme prescriptions for new Wellness Life brand

Week 33 Wrap: US recession fears forgotten; RBNZ’s surprise rate cut; more iron ore trouble

Emerald & Azure score Digger & Dealer awards

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Excellent roundup of progress to date RBx. A timely reminder of...

Top Stories

Victory Metals dips -8% even as company set to grow heavy REE resource at North Stanmore

Argent begins search for VMS mineralisation at Kempfield Cu-Pb-Zn-Au-Ag play in NSW

EIS co-funded campaign sees Miramar kick off maiden drilling at Bangemall, Gascoyne WA

Court of Appeal upholds environmental group's challenge to Silver Mines Ltd's Bowden project

IMDEX to receive $10M in out-of-court settlement with Boart Longyear over downhole tool patent

EQ Resources transitions historic Mt Carbine tungsten mine to owner-operator system

Bitcoin: Current State of Play & Where to Next | Swyftx

Wellnex sees first special access scheme prescriptions for new Wellness Life brand

Week 33 Wrap: US recession fears forgotten; RBNZ’s surprise rate cut; more iron ore trouble

Emerald & Azure score Digger & Dealer awards

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News